Skip to main content
. 2012 Jun 11;51(28):7035–7040. doi: 10.1002/anie.201201955

Figure 4.

Figure 4

A) In situ ABPP labeling of human brain cancer cells (insoluble fraction, for the whole proteome see Figure S5 in the Supporting Information) with probes P1 (lanes 5 and 6) and P3 (lanes 2–4). Competitive labeling with MAO inhibitors deprenyl (Dep) and pargyline (Par) and probe P3 (lanes 7 and 8). B) Comparison of fluorescence scanning (FS) and Coomassie Brilliant Blue (CBB) staining of labeling by the probe P3. C) Identification of lower band by Western blotting (WB) using specific anti-MAO B antibodies.